Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

Shreyaskumar Patel, Margaret von Mehren, Damon R. Reed, Pamela Kaiser, John Charlson, Christopher W. Ryan, Daniel Rushing, Michael Livingston, Arun Singh, Rahul Seth, Charles Forscher, Gina D'Amato, Sant P. Chawla, Sharon McCarthy, George Wang, Trilok Parekh, Roland Knoblauch, Martee L. Hensley, Robert G. Maki, George D. Demetri

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences